You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for Patent: 6,121,291


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,121,291
Title: Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder
Abstract:This invention relates to the use of paroxetine or a pharmaceutically acceptable salt thereof for the treatment of post-traumatic stress disorder and depression associated with withdrawal from heroin abuse.
Inventor(s): Gleason; Maurice (Newbury, GB)
Assignee: SmithKline Beecham plc (Brentford, GB)
Application Number:09/142,990
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,121,291

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,121,291

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9605828Mar 20, 1996
PCT Information
PCT FiledMarch 17, 1997PCT Application Number:PCT/EP97/01353
PCT Publication Date:September 25, 1997PCT Publication Number: WO97/34602

International Family Members for US Patent 6,121,291

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus 2482 ⤷  Sign Up
Germany 69721756 ⤷  Sign Up
European Patent Office 0893997 ⤷  Sign Up
European Patent Office 1300144 ⤷  Sign Up
Spain 2199357 ⤷  Sign Up
United Kingdom 9605828 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.